Nov 6, 2025, 07:07
Who Is Eligible for CAR T-Cell Therapy? Expert Perspectives on Overcoming Referral Barriers
Raul Cordoba, Associate Chief at the Department of Hematology at Jiménez Díaz Foundation, shared a post on X:
”Who Is Eligible for CAR T-Cell Therapy? Expert Perspectives on Overcoming Referral Barriers”
Read the full article here.
Title: Who Is Eligible for CAR T-Cell Therapy? Expert Perspectives on Overcoming Referral Barriers
Authors: Mazyar Shadman, Sairah Ahmed, Michael T. Byrne, Julio C. Chavez, Manali Kamdar, Mohamed L. Sorror, Miguel-Angel Perales, Joshua A. Hill, Javid Moslehi, David B. Miklos
Stay informed with Hemostasis Today.
Car T-Cell Therapy
CAR-T cell
David B. Miklos
Health
Hematology
Hemostasis
Hemostasis Today
Javid Moslehi
Jiménez Díaz Foundation
Joshua A. Hill
Julio C. Chavez
Manali Kamdar
Mazyar Shadman
Medicine
Michael T. Byrne
Miguel-Angel Perales
Mohamed L. Sorror
Oncology
Raul Cordoba
Sairah Ahmed
thrombosis
-
May 14, 2026, 05:19Tackling Cardiovascular Comorbidities in Bleeding Disorders – EHC
-
May 13, 2026, 17:38Rohit Sankar J. Snscphysio: Recognizing the Clot Before It Becomes Life-Threatening
-
May 13, 2026, 16:41Seema Dawood: When Elevated Platelets Signal a Myeloproliferative Neoplasm
-
May 13, 2026, 16:38Kari Tikkinen: Defining Thromboprophylaxis in MIBC Neoadjuvant Care
-
May 13, 2026, 16:28Nadia Tarhini: Evaluating the Risk of Recurrent Thrombosis in Children with ALL
-
May 13, 2026, 16:01Sifat Jubaira: When Low MCV Meets High Platelets
-
May 13, 2026, 15:58Aktham El-rekaby: Immunothrombosis in Acute Ischaemic Stroke
-
May 13, 2026, 15:49Alison Dougall: Oral Health and Cardiovascular Risk in Bleeding Disorders
-
May 13, 2026, 15:38International Journal of Stroke: Oral Anticoagulants and DOAC–Antiplatelet Therapy Are Associated with Increased Major Bleeding Risk